Cat.No.L2200
A unique collection of 1417 small molecules targeting G protein coupled receptors for high throughput screening (HTS) and high content screening (HCS).
Cited by 332 Publications
•A unique collection of 1417 small molecules targeting G protein coupled receptors for high throughput screening (HTS) and high content screening (HCS)
• All of the small molecules in the GPCR library are well characterized with biological and pharmaceutical activity
• A powerful tool for discovering GPCR-based drugs that are the richest signal receptor targets for drug discovery
• It is estimated about 200 so-called orphan GPCRs are functionally unknown, as a result, use of our GPCR Small Molecule Compound Library for screening the functionally unknown GPCRs may yield potentially new GPCR-based drug candidates
• The GPCR compound library contains small molecules associated with receptors including 5-HT Receptor, Dopamine Receptor, Opioid Receptor, Adrenergic Receptors, Cannabinoid Receptor, mGluR, and ETA-receptor etc.
• Structurally diverse, medicinally active, and cell permeable
• Rich documentation with structure and customer reviews
• NMR and HPLC validated to ensure the highest purity
| Formulation | 1299 compounds pre-dissolved in 10mM DMSO, 76 compounds pre-dissolved in 10mM water, 37 compounds pre-dissolved in 2mM DMSO and 5 compounds pre-dissolved in 2mM water | ||
|---|---|---|---|
| Container | 96 Deep Well Plate Sealed With Aluminium Foil | ||
| Stability | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Shipping | Blue ice or dry ice | ||
Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF
Application of Epigenetics Compound Library in acute lymphoblastic leukaemia (This article was published in Blood (IF
Application of Inhibitor Library in tumour immunology (This article was published in Cancer Immunol Res (IF